Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...

Background Amyotrophic lateral sclerosis (ALS) is a progressive and usually fatal neurodegenerative disease. Survival from diagnosis varies considerably. Several prognostic factors are known, ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

1 Farr Institute of Health Informatics, University College London, London, UK 2 Stroke and Vascular Research Centre, Institute of Cardiovascular Sciences, University of Manchester, Manchester Academic ...

OBJECTIVES Temporal lobe atrophy as assessed by MRI can be measured in several ways. Volumetric measurements are quantitative but very time consuming and require extensive training to perform, so are ...

Service de Neurologie, Centre Hospitalo-Universitaire, 3 Rue du Faubourg, Raines, 21000 Dijon, France Professor M Giroud, Service de Neurologie, Centre Hospitalo-Universitaire, 3 Rue du Faubourg, ...

1 Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Cardiff, UK 2 Department of Neurology, University Hospital of Wales, Cardiff, UK 3 ...

OBJECTIVES To examine the occurrence of hallucinations and delusions in Alzheimer's disease over a 4 year period and their association with rate of cognitive decline. METHODS A cohort of 410 persons ...

A case study investigates the writing, spelling and praxic skills of one patient who was found to have a selective impairment in his ability to write letters and words in the absence of difficulty in ...

Background: There are inconsistencies in published reports regarding the profile of cognitive impairments in vascular dementia, and its differentiation from Alzheimer’s disease. Objectives: To ...

Background: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and exclusion of other known causes of the neurological symptoms, but this criterion does not separate ...